Pallidal Versus Subthalamic Deep-Brain Stimulation for Generalized Isolated Dystonia: A Retrospective Study

Area of Science:

• Neurosurgery
• Neurology
• Medical Devices

Background:

• Deep-brain stimulation (DBS) is a key treatment for medically refractory dystonia.
• Choosing the optimal DBS target is crucial for maximizing therapeutic benefits.

Purpose of the Study:

• To compare the therapeutic advantages of two primary DBS targets: the globus pallidus interna (GPi) and the subthalamic nucleus (STN).
• To evaluate the efficacy of STN-DBS versus GPi-DBS in patients with generalized isolated dystonia.

Main Methods:

• A retrospective study of 29 patients with generalized isolated dystonia who underwent DBS.
• Patients received either GPi-DBS or STN-DBS.
• Symptom severity (BFMDRS-M), daily living activities (BFMDRS-D), and quality of life (SF-36) were assessed.

Main Results:

• STN-DBS group showed a significantly higher percentage improvement in BFMDRS-M scores at 6 months (63.91%) compared to the GPi-DBS group (38.36%).
• Arm symptom improvement was substantially greater with STN-DBS (up to 80.66%) versus GPi-DBS (around 38.47%) at 12 months.
• Both groups experienced improvements in quality of life across all SF-36 subscales at 12 months.

Conclusions:

• STN-DBS demonstrates greater advantages than GPi-DBS for generalized isolated dystonia, particularly in cases with significant arm involvement.
• STN-DBS achieved superior clinical outcomes within the initial six months post-surgery compared to GPi-DBS.